1959-1963 - Whitesboro Central High School, New York State Regents Diploma, Whitesboro, NY

1963-1967 - BS, Biology, Saint Lawrence University, Canton, NY

1967-1972 - PhD, Biochemical Pharmacology, The State University of New York at Buffalo, conferred 1973, Buffalo, NY

1967 - Olson Memorial Summer Fellow with Dr. Gordon K. Moe, Masonic Medical Research Laboratory, Utica, NY

1967-1972 - Predoctoral Fellow with Dr. Enrico Mihich, Departments of Biochemical Pharmacology, State University of New York at Buffalo, and Experimental Therapeutics, Roswell Park Memorial Institute, Buffalo, NY

1973-1976 - Postdoctoral Fellow with Dr. Lloyd J. Old, Melanoma Serology Laboratory, Sloan-Kettering Institute, NY, NY

RETURN TO TOP

ACADEMIC APPOINTMENTS:

1976 - 1978 - Research Associate, Human Cancer Serology Laboratory, Sloan-Kettering Institute, New York, NY

1978 - 1986 - Assistant Research Scientist, Department of Otorhinolaryngology, University of Michigan Medical School, Ann Arbor, MI

1978 - 1986 - Assistant Research Scientist, Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI

1986 - 1992 - Associate Research Scientist, Department of Otolaryngology/Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, MI

1992 – 1997 - Research Scientist, Department of Otolaryngology/Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, MI

1997 – 1999 - Senior Research Scientist, Department of Otolaryngology/Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, MI

1999 - present - University Distinguished Research Scientist, Department of Otolaryngology/Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, MI

1999 - present - Co-Director, Head and Neck Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

2000 - present - Associate Chair and Director of Research, Department of Otolaryngology/Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, MI

2000 - present - Professor, Department of Otolaryngology/Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, MI

2001 -present - Professor and Chair, Department of Oral Medicine, Pathology and Oncology, University of Michigan Dental School, Ann Arbor, MI

RETURN TO TOP

PUBLICATIONS:

Refereed Journals

  1. Mawas C, Carey TE and Mihich E. Study of the immune responses to nucleated cells. I. In Vitro functional evaluation of the immune effectors responsible for complement dependent cellular cytotoxicity. Cellular Immunol 6:243-260, 1973.
2. Mawas C, Carey TE and Mihich E. Role of cellular antigens in humoral and cell-mediated immunity as measured in vitro. Proc. Soc. Exp Biol Med 144:945-951, 1973.
3. Carey TE, Takahashi T, Resnick LA, Oettgen HF and Old LJ. Cell surface antigens of human malignant melanoma: Mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci USA 73:3278-3282, 1976.
4. Kornbluth J, Pollack MS, Fogh J, Carey T and Dupont B. HLA typing of human tumor cell lines: Selection of appropriate typing techniques. Transplant Proc 9:735-738, 1978.
5. Carey TE, Takahashi T, Lloyd KO, Travassos LR and Old LJ. AU cell-surface antigen of human malignant melanoma: Solubilization and partial characterization. Proc Natl Acad Sci USA 76:2898-2902, 1979.
6. Pollack MS, Livingston PO, Fogh J, Carey TE, Oettgen HF and Dupont B. Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell lines. Tissue Antigens 15:249-256, 1980.
7. Krause CJ, Carey TE, Ott RW, Hurbis C, McClatchey KD and Regezi JA. Human squamous cell carcinoma: Establishment and characterization of new permanent cell lines. Arch Otolaryngol 107:703-710, 1981.
8. Carey TE. Immunologic Aspects of Melanoma. CRC Critical Reviews in Clinical Laboratory Sciences 18:141-182, 1982.
9. Lewis FH, Beals TF, Carey TE, Baker SR and Mathews KP. Ultra structural and functional studies of cilia from patients with asthma, aspirin intolerance, and nasal polyps. Chest 83:487-490, 1983.
10. Virolainen E, Carey TE, Wicha M and Krause CJ. Factors affecting the growth of head and neck squamous carcinoma cell lines. Otolaryngol Head & Neck Surg 5:126-138, 1983.
11. Jones C, Kimmel KA, Carey TE, Miller YE, Lehman DW and MacKenzie D. Further studies on a hybrid cell-surface antigen associated with human chromosome 11 using a monoclonal antibody. Somat Cell Genet 9:489-496, 1983.
12. Carey TE, Kimmel KA, Schwartz DR, Richter DE and Krause CJ. Antibodies to human squamous cell carcinomas. Otolaryngol Head and Neck Surg 91:482-491, 1983.
13. Virolainen E, Vanharanta R and Carey TE. Steroid hormone receptors in human squamous carcinoma cell lines. Int J Cancer 33:19-25, 1984.
14. Spiegel J, Carey TE, Shimoura S and Krause CJ. In vitro sensitivity and resistance of cultured human squamous carcinoma cells to cis-platinum and methotrexate. Otolaryngol Head and Neck Surg 92:534-531, 1984.
15. Fisher JH, Miller YE, Sparkes RS, Bateman JB, Kimmel KA, Carey TE, Rodell T, Shoemaker S A, and Scoggin CH. Wilms' tumor-aniridia association: Segregation of the affected chromosome in somatic cell hybrids. Identification of a cell surface antigen associated with the deleted area, and regional mapping of the C-Ha-ras-1 oncogene, insulin gene and beta-globin gene. Somat Cell Genet 10:455-464, 1984.
16. Grossman HB, Wedemeyer G, Ren L and Carey TE. UM-SCP-1: A New Human Cell Line Derived from a Prostatic Squamous Cell Carcinoma. Cancer Res 44:4111-4117, 1984.
17. Roa RA, Carey TE, Passamani PP, Greenwood JH, Hsu S, Ridings EO, Wolf GT and Hudson JL. DNA content of human squamous cell carcinoma cell lines: Analysis by flow cytometry and chromosome enumeration. Arch Otolaryngol 111:565-575, 1985.
18. Kimmel KA, Carey TE, Judd WJ and McClatchey KD. Monoclonal antibody G10 to an antigen common to human squamous cell carcinomas binds to the H type 2 blood group determinant. JNCI 76:9-19, 1986.
19. Rosenblum BB, Judd WJ and Carey TE. Detection of ABH glycoproteins from erythrocyte membranes on Western blots using monoclonal and polyclonal antibodies. Hybridoma 5:117-127, 1986.
20. Kimmel KA and Carey TE. Altered expression in squamous carcinoma cells of an orientation-restricted epithelial antigen detected by monoclonal antibody A9. Cancer Res 46:3614-3623, 1986.
21. Shapira A, Virolainen E, Ossakow S, Jameson JJ and Carey TE. Growth inhibition of laryngeal UM-SCC cell lines by tamoxifen: Comparison to effects on the MCF-7 breast cancer cell line. Arch Otolaryngol 112:1151-1157, 1986.
22. Grenman R, Virolainen E, Shapira A and Carey TE. In vitro effects of tamoxifen on UM-SCC head and neck cancer cell lines: Correlation with the estrogen and progesterone receptor content. Int J Cancer 39:77-81, 1987.
23. Varani J, Dixit VM, Fligiel SEG, McKeever PE and Carey TE. Thrombospondin-induced attachment and spreading of human squamous carcinoma cells. Exp Cell Res 156:1-15, 1987.
24. Wahl RL, Kimmel KA, Beierwaltes WH and Carey TE. Radioimmunodiagnosis of human derived squamous cell carcinoma. Hybridoma 6:111-119, 1987.
25. Carey TE, Wolf GT, Hsu S, Poore J, Peterson K, and McClatchey KD. Expression of A9 antigen and loss of blood group antigens as determinants of survival in patients with head and neck squamous carcinoma. Otolaryngol Head Neck Surg 96:221-230, 1987.
26. Varani J, Carey TE, Fligiel SEG, McKeever PE and Dixit V. Tumor type-specific differences in cell-substrate adhesion among human tumor cell lines. Int J Cancer 39:397-403, 1987.
27. Grenman SE, Shapira A, and Carey TE. In vitro response of cervical cancer cell lines CaSki, HeLa, and ME-180 to the antiestrogen tamoxifen. Gynecologic Oncology 30:228-238, 1988.
28. Grenman SE, Roberts JA, England BG, Gronroos M and Carey TE. In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate. Gynecologic Oncology 30:239-250, 1988.
29. Sprik S A, Sullivan MJ and Carey TE. In vitro photosensitization of human head and neck squamous cancer cells by dihematoporphyrin-ether. Otolaryngol Head Neck Surg 99:28-37, 1988.
30. Grenman SE, Van Dyke DL, Worsham MJ, del Rosario F, Roberts JA, McClatchey KD, Schwartz DR, Babu VR and Carey TE. UM-EC-1, a new hypodiploid human cell line derived from a poorly differentiated endometrial cancer. Cancer Res 48:1864-1873, 1988.
31. Shapira A, Wagner JG, Wollner IS, Maybaum J, Stetson PL, Ensminger WD and Carey TE. Dynamics of bromodeoxyuridine incorporation into DNA of squamous carcinoma cells during mid and late logarithmic growth. Pharmaceutical Res 5:518-522, 1988.
32. Grenman R, Burk D, Virolainen E, Wagner JG, Lichter AS and Carey TE. Radiosensitivity of head and neck cancer cells in vitro: A 96 well plate clonogenic cell assay for squamous cell carcinoma, Arch Otolaryngol 114:427-431, 1988.
33. Frenette G, Carey TE, Varani J, Schwartz D, Fliegel S, Ruddon R and Peters B. Biosynthesis and secretion of laminin and laminin-associated glycoproteins by nonmalignant and malignant human keratinocytes: Comparison of cell lines from primary and secondary tumors in the same patient. Cancer Res, 48:5193-5202, 1988.
34. Wolf GT, Carey TE, Hayashida DJ, Poore J, Davis L, McClatchey KD and Grenman R. Monoclonal antibodies as prognostic indicators in patients with squamous cancer of the oral cavity and oral pharynx. Acta Otolaryngologica (Stockh) 449:229-234, 1988.
35. Vlock DR, Scalise D, Schwartz DR, Richter DE, Krause CJ, Baker SR and Carey TE. Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration. Cancer Res 49:1361-1365, 1989.
36. Varani J, Riser BL, Hughes LA, Carey TE, Fligiel SEG and Dixit VM. Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cells. Clin Expl Metastasis 3:265-276, 1989.
37. Pekkola-Heino K, Kulmala J, Grenman S, Carey TE and Grenman R. Radiation response of vulvar squamous cell carcinoma (UM-SCV-1B, UM-SCV-2, and A-431) cells in vitro. Cancer Res 49:4876-4878, 1989.
38. Grenman R, Burk D, Virolainen E, Buick RN Church J and Carey TE. Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. Int J Cancer 44:131-136, 1989.
39. Carey TE, Van Dyke DL, Worsham MJ, Bradford CR, Babu VR, Schwartz DR, Hsu S and Baker SR. Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B. Cancer Res 49:6098-6107, 1989.
40. Bradford CR, Hoffman HT, Wolf GT, Carey TE, Baker SR and McClatchey KD. Squamous carcinoma of the head and neck in organ transplant recipients: Possible role of oncogenic viruses. Laryngoscope 100: 190-194, 1990.
41. Urba SG, Carey TE, Kudla-Hatch V, Wolf GT and Forastiere AA. Tamoxifen therapy in patients with recurrent laryngeal squamous carcinoma. Laryngoscope 100:76-78, 1990.
42. Grenman SE, Worsham MJ, Van Dyke DL, England B, McClatchey KD, Babu VR, Roberts JA, Maenpaa J and Carey TE. Establishment and characterization of UM-EC-2, a tamoxifen sensitive estrogen receptor negative human endometrial carcinoma cell line. Gynecol Oncol 37:188-199, 1990.
43. Grenman SE, Van Dyke DL, Worsham MJ, England B, McClatchey KD, Hopkins M, Babu VR, Grenman R and Carey TE. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines - UM-SCV-1A and UM-SCV-1B. Int J Cancer 45:920-927, 1990.
44. Hoffman HT, Subnani M, Cha M, Kidd L, Landman J, Tooley R and Carey TE. Calcium-dependent regulation of cell surface antigen expression on normal and malignant human squamous cells in vitro. Arch Otolaryngol Head Neck Surg 116:299-303, 1990.
45. Schuger L, Dixit VM, Carey TE and Varani J. Modulation of squamous carcinoma cell growth, morphology, adhesiveness and extracellular matrix production by interferon-g and tumor necrosis factor-a. Pathobiology 58:279-286, 1990.
46. Wolf GT, Carey TE, Schmaltz SP, McClatchey KD, Poore J, Glaser L, Hayashida DJS and Hsu S. Altered antigen expression predicts outcome in squamous carcinoma of the head and neck. J Natl Cancer Inst 82:1566-1572, 1990.
47. Liebert M, Wedemeyer G, Chang JHC, Stein JA, McKeever PE, Carey TE, Flint A, Steplewski Z, Buchsbaum DJ, Wahl RL and Grossman HB. Comparison of antigen expression on normal urothelial cells in tissue section and tissue culture. J Urology 144:1288-1292, 1990.
48. Zajic G, Nair TS, Ptok M, Van Waes C, Altschuler RA, Schacht J and Carey TE. Monoclonal antibodies to inner ear antigens: I. Antigens expressed by supporting cells in guinea pig cochlea. Hearing Res 52:59-72, 1991.
49. Bradford CR, Zacks SE, Androphy EJ, Gregoire L, Lancaster WD, and Carey TE. Human papillomavirus DNA sequences in cell lines derived from head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg 104:303-310, 1991.
50. Van Waes C, Kozarsky KF, Warren AB, Kidd L, Paugh D, Liebert M and Carey TE. The A9 antigen associated with aggressive human squamous carcinoma has structural and functional similarity to the newly defined integrin a6b4. Cancer Res 51:2395-2402, 1991.
51. Grenman R, Carey TE, McClatchey KD, Wagner JG, Pekkola-Heino K, Schwartz DR, Wolf GT, Lacivita LP, Ho L, Baker SR, Krause CJ and Lichter AS. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer 67:2741-2747, 1991.
52. Bradford CR, Kimmel KA, Van Dyke DL, Worsham MJ, Tilley BJ, Burk D, del Rosario F, Lutz S, Tooley R, Hayashida DJS and Carey TE. 11p deletions and breakpoints in squamous cell carcinoma: Association with altered reactivity with the UM-E7 antibody. Genes Chromosomes Cancer 3:272-282, 1991.
53. Worsham MJ, Van Dyke DL, Grenman SE, Grenman R, Hopkins MA, Robert JA, Gasser KM, Schwartz DR and Carey TE. Consistent chromosome abnormalities in squamous carcinoma of the vulva. Genes Chromosomes Cancer 3:420-432, 1991.
54. Ptok M, Nair TS, Altschuler RA, Schacht J and Carey TE. Monoclonal antibodies to inner ear antigens: II. Antigens expressed in sensory cell stereocilia. Hear Res 57:79-90, 1991.
55. Vlock DR, Arnold B, Humpierres J, Schwartz DR, Baker SR, Krause CJ, Swanson N and Carey TE. Serial studies of autologous antibody reactivity to squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 34:329-336, 1992.
56. Carey TE, Laurikainen L, Nair TS, Reinke TS, Coling DE, Wolf GT, Van Waes C, Liebert M and Marcelo C. Regulation of expression and phosphorylation of A9/a6b4 integrin in normal and neoplastic keratinocytes. J Natl Cancer Inst Monograph 13, pp. 75-86, 1992.
57. Wolf GT and Carey TE. Tumor antigen phenotype, biologic staging and prognosis in head and neck squamous carcinoma. J Natl Cancer Inst Monograph 13, pp. 67-74, 1992.
58. Grossman HB, Washington RW Jr, Carey TE and Liebert M. Alterations in antigen expression in superficial bladder cancer. J Cell Biochem Suppl 16I: 63-68, 1992.
59. Worsham MJ, Benninger MJ, Zarbo RJ, Carey TE and Van Dyke DL. Deletion 9p22-pter and loss of Y as primary chromosome abnormalities in a squamous cell carcinoma of the vocal cord. Genes Chrom Cancer 6:58-60, 1993.
60. Liebert M, Wedemeyer G, Stein JA, Washington RW Jr, Van Waes C, Carey TE, and Grossman HB. The monoclonal antibody BQ16 identifies the a6b4 integrin on bladder cancer. Hybridoma 12:67-80, 1993.
61. Vlock DR, Toporowicz A, Arnold B, Aul D, McCoy JP Jr, Carey TE and Brown WE. Isolation and purification of a squamous cell carcinoma of the head and neck-associated antigen identified by autologous antibody. Biochim Biophy Acta 1181:174-182, 1993.
62. Carey TE, Worsham MJ and Van Dyke DL. Chromosomal biomarkers in the clonal evolution of head and neck squamous neoplasia. J Cell Biochem Suppl 17F:213-222, 1993.
63. Carey TE, Nair TS, Chern C, Liebert M, Grossman HB, Wolf GT and Van Waes C. Blood group antigens and integrins as biomarkers in head and neck cancer: Is aberrant tyrosine phosphorylation the cause of altered a6b4 integrin expression? J Cell Biochem Suppl 17F:223-232, 1993.
64. Worsham MJ, Carey TE, Benninger MS, Gasser KM, Kelker W, Zarbo RJ and Van Dyke DL. Clonal cytogenetic evolution in a squamous cell carcinoma of the skin from a xeroderma pigmentosum patient, HFH-SCC-XP-1. Genes Chromosomes Cancer 7:158-164, 1993.
65. Ptok M, Nair T, Carey TE, and Altschuler RA. Distribution of KHRI-3 epitopes in the inner ear. Hear Res 66:245-252, 1993.
66. Ptok M, Carey TE and Altschuler RA. Relationship of monoclonal antibody (KHRI 3 epitope) to cochlear supporting cell microvilli in the guinea pig. Eur Arch Otorhinolaryngol 250:345-350, 1993.
67. Vlock DR, Carey TE, Schantz SP, Fisher SG and Wolf GT. Clinical correlates of circulating immune complexes and antibody reactivity in squamous cell carcinoma of the head and neck. J Clin Oncol 11:2427-2433, 1993.
68. Carey TE, Van Dyke DL and Worsham MJ. Nonrandom chromosome aberrations and clonal populations in head and neck cancer. Anticancer Res 13:2561-2568, 1993.
69. Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T and Carey TE. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer 9:192-206, 1994.
70. Liebert M, Washington R, Wedemeyer G, Carey TE and Grossman HB. Loss of co-localization of a6b4 integrin and collagen VII in bladder cancer. Am J Path 144:787-795, 1994.
71. Nair TS, Raphael Y, Dolan DF, Parrett TJ, Perlman LS, Brahmbhatt VR, Wang Y, Hou X, Gholizadeh G, Nuttall AL, Altschuler RA and Carey TE. Monoclonal antibody induced hearing loss. Hear Res 83:101-113, 1995.
72. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benninger MS and Van Dyke DL. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: Analysis by tumor karyotype and fluorescence in situ hybridization. Human Path 26:251-261, 1995.
73. Beck JC, McClatchey KD, Lesperance MM, Esclamado RM, Carey TE and Bradford CR. Presence of human papillomavirus predicts recurrence of inverted papilloma. Otolaryngol Head Neck Surg 113:49-55, 1995.
74. Beck JC, McClatchey KD, Lesperance MM, Esclamado RM, Carey TE and Bradford CR. Human papillomavirus types important in progression of inverted papilloma. Otolaryngol Head Neck Surg 113:558-563, 1995.
75. Hietanen S, Grenman S, Syrjanen K, Lappalainen K, Kauppinen J, Carey T and Syrjanen S. Human papillomavirus in vulvar and vaginal carcinoma cell lines. Brit J Cancer 72134-139, 1995.
76. Carey TE. Genetic mechanisms in the development and progression of head and neck cancer. Current Opinion in Otolaryngol HN Surg 3:75-78, 1995.
77. Bradford CR, Zhu S, Wolf GT, Poore J, Fisher SG, Beals T, McClatchey KD, Carey TE and the VA Laryngeal Cancer Study Group. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Otolaryngol Head Neck Surg 113:408-412, 1995.
78. Van Waes C, Surh DM, Chen Z, Kirby M, Rhim JS, Brager R, Sessions RB, Kashima H, Poore J, Wolf GT and Carey TE. Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res 55:5434-5444, 1995.
79. Hietanen SH, Kurvinen K, Syrjanen K, Grenman S, Carey T, McClatchey K and Syrjanen S. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells. Am J Obstet Gynecol 173:1477-1482, 1995.
80. Varani J, Trinh D, Carey TE, Liebert M. and Wheelock, MJ. Expression of cell surface adhesion molecules on the epithelium of organ-cultured skin. Invasion & Metastasis 15:189-196, 1995.
81. Lalwani A, Carey TE, Goldstein IJ and Peters BP. Lectin binding characteristics of squamous cell carcinomas of the head and neck. Acta Oto-Laryngologica (Stockh) 116:125-131, 1996.
82. Wideroff L, Schottenfeld D, Carey TE, Beals T, Fu G, Sakr W, Sarkar F, Schork A, Grossman HB and Shaw MW. Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males. The Prostate 28:117-123, 1996.
83. Carey TE. Field cancerization: Are multiple primary cancers monoclonal or polyclonal? Ann Med 28:183-188, 1996.
84. Laurikainen L, Carey T and Peltonen J. The expression of a6 and b4 integrin genes are differentially regulated by all-trans retinoic acid (RA) in cultured human keratinocytes. Arch Dermatol Res 288:270-273, 1996.
85. Buchhagen DL, Worsham MJ, Van Dyke DL and Carey TE. Two regions of hemizygosity on chromosome 3p correlate with cytogenetic losses in squamous cell carcinoma of the head and neck. Head and Neck 18:529-537, 1996.
86. Kelker W, Van Dyke DL, Worsham MJ, Christopherson PL, James CD, Conlon MR, and Carey TE. Loss of 18q and homozygosity for the DCC locus: Possible markers for clinically aggressive squamous cell carcinoma. Anticancer Res 16:2365-2372, 1996.
87. Islam S, Carey TE, Wheelock MJ and Johnson KR. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell to cell adhesion. J Cell Biol 135:1643-1654, 1996.
88. Varani, J, Zeigler, ME, Perone, P, Carey, TE, Datta, SC. Human squamous carcinoma cell invasion in organ-cultured skin. Cancer Lett 111:51-7, 1997.
89. Kim S-Y, Bachman NJ, Nair TS, Goldsmith S, Liebert M, Grossman HB, Lomax MI, and Carey TE. b4 integrin transfection of UM-UC-2 (human bladder carcinoma) cells: Stable expression of a spontaneous cytoplasmic truncation mutant with rapid loss of clones expressing intact b4. Cancer Res 57:38-42, 1997.
90. Frank CJ, McClatchey KD, Devaney KO, and Carey TE. Evidence that loss of chromosome 18q is associated with tumor progression. Cancer Res 57:824-827, 1997.
91. Nair TS, Prieskorn DM, Miller JM, Mori A, Gray J, and Carey TE. In vivo binding and hearing loss after intracochlear infusion of KHRI-3 antibody. Hear Res 107:93-101, 1997.
92. Jones JW, Raval JR, Beals TF, Worsham MJ, Van Dyke DL, Esclamado RM, Wolf GT, Bradford CR, Miller T, and Carey TE. Frequent loss of heterozygosity on chromosome 18q in squamous cancers: Identification of two regions of loss -- 18q11.1-12.3, and 18q21.1-23. Arch Otolaryngol Head Neck Surg 123:610-614, 1997.
93. Carey TE, Frank CJ, Raval JR, Jones JW, McClatchey KD, Beals TF, Worsham MJ and Van Dyke DL. Identifying genetic changes associated with tumor progression in squamous cell carcinoma. Acta Otolaryngol (Stockh) Suppl 529:229-232, 1997.
94. Van Waes C, Surh DM, Chen Z and Carey TE. Inhibition of integrin mediated cell adhesion of human head and neck squamous cell carcinoma to extracellular matrix laminin by monoclonal antibodies. Intl J Oncol 11:457-464, 1997.
95. Bradford CR. Zhu S, Poore J, Fisher SG, Beals TF, Thoraval D, Hanash SM, Carey TE, Wolf GT, and the Department of Veterans Affairs Laryngeal Cancer Study Group. p53 mutation as a prognostic marker in advanced laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 123:605-609, 1997.
96. Xia L, Stoll SW, Liebert M, Ethier SP, Carey T, Esclamado R, Carroll W, Johnson TM, Elder JT. CaN19 expression in benign and malignant hyperplasias of skin and oral mucosa: Evidence for a role in regenerative differentiation. Cancer Res 57:3055-3062, 1997.
97. Disher MJ, Ramakrishnan A, Nair TS, Miller JM, Telian SA, Arts AA, Sataloff RT, Altschuler RA, Raphael Y, and Carey TE. Human autoantibodies and monoclonal antibody KHRI-3 bind to a phylogenetically conserved inner ear supporting cell antigen. Ann NY Acad Sci 830:253-265, 1997.
98. Kim SY, Chu K-C, Lee HR, Lee K-S, Carey TE. Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol (Stockh) 117:775-784, 1997.
99. Harris MO, Beck JC, Terell JE, McClatchey KD, Carey TE and Bradford CR. Expression of human papillomavirus 6 in inverted papilloma arising in a renal transplant recipient. Laryngoscope 108:115-119. 1998.
100. Harris MO, Beck JC, Lancaster W, Gregoire L, Carey TE and Bradford CR. The HPV 6 E6/E7 genes are expressed in inverted papilloma. Otolaryngol Head Neck Surg 118:312-318, 1998.
101. Pearlstein RP, Benninger MS, Carey TE, Zarbo RJ, Torres FX, Rybicki BA, and Van Dyke DL. Loss of 18q predicts poor survival in patients with squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer 21:333-339, 1998.
102. Kim SY, Han IS, Yu HK, Lee HR, Chung JW, Choi JH, Kim SH, Byun Y, Carey TE, Lee KS. The induction of P450-mediated oxidation of all-trans retinoic acid by retinoids in head and neck squamous cell carcinoma cell lines. Metabolism: Clinical Experimental 47:955-958, 1998.
103. Arosarena OA, Baranwal S, Strome S, Wolf GT, Krauss JC, Bradford CR Carey, TE. Expression of major histocompatibility complex antigens in squamous cell carcinomas of the head neck: Effects of interferon gene transfer. Otolaryngol Head Neck Surg 120:665-671, 1999.
104. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benninger MS and Van Dyke DL. Chromosomal aberrations identified in culture of squamous carcinomas are confirmed by fluorescence in situ hybridization. J Clin Pathol: Mol Pathol 52:42-46, 1999.
105. Nair TS, Prieskorn DM, Garrett D, Miller JM, Dolan DF, Raphael Y, Carey TE. KHRI-3 monoclonal antibody-induced damage to the inner ear: Antibody staining of nascent scars. Hear Res 129:50-60, 1999.
106. Bradford CR, Wolf GT, Carey TE, Zhu S, Beals T, Truelson J, McClatchey KD, Fisher SG. Predictive Markers for Response to Chemotherapy, Organ Preservation and Survival in Patients with Advanced Laryngeal Carcinoma.. Otolaryngol Head Neck Surg 121:534-538, 1999.
107. Moore CE, Wiatrak BJ, Bradford CR, Carey TE, et al. High-risk human papillomavirus types and squamous cell carcinoma in patients with respiratory papillomas. Otolaryngology-Head and Neck Surgery 120:698-705, 1999.
108. Sisk E, Bradford CR, Jacob A, Yian CH, Staton KM, Tang G, Harris MO, Carey TE, Lancaster WD, Gregoire L. Human papillomavirus infection in "young" versus "old" patients with squamous cell carcinoma of the head and neck. Head Neck 22:649-657, 2000.
109. Sun JD, Weatherly RA, Koopmann CF Jr, Carey TE. Mucosal swabs detect HPV in laryngeal papillomatosis patients but not family members. Intl J Ped Otorhinolaryngol 55:95-103, 2000.
110. Takebayashi, S, Ogawa, T, Jung, K-Y, Muallem, A, Mineta, H, Fisher, S.G., Grenman, R, Carey, TE. Identification of New Minimally Lost Regions on 18q in Head and Neck Squamous Cell Carcinoma. Cancer Res 60:3397-3403, 2000.
107. Kim SH, Carey TE, Liebert M, Yoo SJ, Kwon, HJ, Kim SY. The characterization of AMC-HN-9, a cell line established from an undifferentiated carcinoma of the parotid gland: Expression of a6b4 with the absence of BP180 and 230. Acta Otolaryngol 120:660-666, 2000.
112. Lasak JM, Sataloff RT, Hawkshaw MJ, Carey TE, Lyons KM, Spiegel JR. Autoimmune Inner Ear Disease: Steriod and Cytotoxic Medical Therapy. Accepted, Ear, Nose and Throat, 2001.

RETURN TO TOP

B. NON PEER-REVIEWED ARTICLES
1. Wolf GT, Carey TE, Veltri R, Renkin R, Maxim P and McClatchey KD. Cell biology and immunology in head and neck squamous carcinoma: Research workshop summary. Head and Neck Surgery 8:301-308, 1986.
2. Schantz SP, Weber RS and Carey TE. Growth and progression of head and neck cancer: A report of the upper aerodigestive cancer task force workshop. Head Neck Surg, Jan/Feb 1988.
3. Wolf GT, Al-Sarraf M, Crissman JD with Carey TE et al. Head and neck oncology research - a summary of the second international head and neck oncology research conference. Head and Neck Surgery 10:S90-S96, 1988.
4. Carey TE, Nair TS, Laurikainen L, Fabian SL and Thacher SM. A9/a6b4 integrin in proliferation and differentiation. Head and Neck Cancer Vol III, Johnson and Didolkar (eds), Elsevier Science Publishers BV, Amsterdam, pp 525-531, 1993.
5. Carey TE, Van Dyke DL, Worsham MJ and Frank CJ. Molecular Biology of Head and Neck Cancer Development and Progression. Otolaryngologia: Polish Journal of Otolaryngology Suppl Nr 28:17-19, 1997.

RETURN TO TOP

C. SUBMITTED FOR PUBLICATION
1. Zeitoun H, Gray J, Arts A, Lansford CD, Lee D, El-Kashlan HK, Telian SA, Denny ED, Ramakrishnan A, Nair TS, Disher MJ, Sataloff RT, Fisher SG, Carey TE. Antibody to Supporting Cells and Steroid Response in Suspected Autoimmune Hearing Loss. Laryngoscope.
2. Akervall J, Kurnit DM, Adams M, Zhu S, FisherSG, Bradford CR, Carey TE.. Amplification and overexpression of cyclin D1 and sensitivity to Cisplatin in squamous cell carcinoma cell lines of the head and neck. Submitted, July 2001, Cancer Res.
3. D’Silva NJ, Mitra R, Henson B, Zhang Z, Kurnit DM, Carey TE. Rap1B, a ras-like protein localizes to the nucleus and cytoplasm in normal and malignant human keratinocytes. In preparation, August 2001.
4. Teknos TN, Cox C, Yoo S, Chepeha DB, Wolf GT, Bradford CR, Carey TE, Fisher SG. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. In preparation, August 2001.

D. BOOKS
1. Wolf GT. and Carey TE (eds.), Head and Neck Oncology Research. Berkeley, Kugler & Ghedini, 1988.

RETURN TO TOP

E. CHAPTERS IN BOOKS
1. Shiku H, Takahashi T, Carey TE, Resnick LA, Oettgen HF and Old LJ. Cell Surface Antigens of Human Cancer. In: Biological Markers of Neoplasia: Basic and Applied Aspects. R.W. Ruddon (ed.). New York, Elsevier North Holland, Inc., pp. 73-90, 1978.
2. Shiku H, Takahashi T, Carey TE, Resnick L, Pfreundschuh M, Ueda R, Oettgen HF and Old LJ. Definition of Cell Surface Antigens of Human Malignant Melanoma, Astrocytoma and Renal Cancer by Typing with Autologous Serum. In: Serological Analysis of Human Cancer Antigens. S.A. Rosenberg (ed.). New York, Academic Press, pp. 305-338, 1980.
3. Oettgen HF, Shiku H, Takahashi T, Carey TE, Resnick L, Ueda R, Pfreundschuh M and Old LJ. Human Cancer Immunology. In: Brain Metastasis. L. Weiss, H.A. Gilbert and J.B. Posner (eds.). Boston, G.K. Hall & Co., pp. 165-185, 1980.
4. Carey TE. Establishment of Epidermoid Carcinoma Cell Lines. In: Head and_Neck Cancer. R.E. Wittes (ed.). London, UK, John Wiley & Sons, Ltd., pp. 287-314, 1985.
5. Carey TE and Hudson JL. Potential application of flow cytometry in the diagnosis of metastatic cancer of the head and neck. In: Treatment of Metastatic Cancer of the Head and Neck, Larson, D.L., Guillamondegui, O.M. and Ballantyne, A.J. (eds.). MacMillan Publishing Co., New York, NY. pp. 41-52, 1986.
6. Carey TE, Wolf GT, Baker SR and Krause CJ. Cell surface antigen expression and prognosis. In : Head and Neck Cancer Volume 2. Fee WE, Goepfert H, Johns ME, Strong E, and Ward PH, (eds.). B.C. Decker Inc., Toronto, pp. 77-82, 1990.
7. Hoffman HT, Merkle S and Carey TE. Head and neck squamous carcinoma cell lines capable of serum-free growth in vitro. In: Head and Neck Cancer Volume 2. Fee WE, Goepfert H, Johns ME, Strong E, and Ward PH, (eds.). B.C. Decker Inc., Toronto, pp. 94-97, 1990.
8. Van Dyke DL, Carey TE, Grenman SE, Worsham MJ, Bradford CR, Grenman R, Babu VR and Schwartz DR. Identification of chromosome changes in squamous cell carcinoma using established cell lines. In : Head and Neck Cancer Volume 2. Fee WE, Goepfert H, Johns ME, Strong E, and Ward PH, (eds.). B.C. Decker Inc., Toronto, pp. 97-102, 1990.
9. Wolf GT, Beals T, Carey TE, Hudson JL, Buiting N, Bradford CR and Peterson KA. Cytophotometric analysis of the DNA content of human head and neck squamous carcinoma cell lines. In: Head and Neck Cancer Volume 2. Fee WE, Goepfert H, Johns ME, Strong E, and Ward PH, (eds.). B.C. Decker Inc., Toronto, pp. 102-108, 1990.
10. Carey TE, Laurikainen L, Ptok A, Reinke T, Linder K, Nair TS and Marcelo C. Culture conditions affect expression of the a6b4 integrin associated with aggressive behavior in head and neck cancer. In: Adv Exp Med Biol. Newell and Hong (eds.). Plenum Publishing Corp., New York, NY, pp. 69-79, 1992.
11. Van Waes C and Carey TE. Overexpression of A9/a6b4 integrin. In: Otolaryngologic Clinics of North America. SC Short (ed.). W.B. Saunders Company, Philadelphia, PA, pp. 1117-1139, 1992.
12. Babu VR and Carey TE. Solid Tumor Cytogenetics. In: Clinical Laboratory Medicine. McClatchey KD (ed.). Williams & Wilkins, Baltimore, MD, pp. 741-766, 1994.
13. Carey TE. Head and neck tumor lines. In: Atlas of Human Tumor Cell Lines. R Hay, A Gazdar and J-G Park (eds.). Academic Press, Inc., Harcourt Brace Jovanovich, Publishers, Orlando, FL, pp. 79-120, 1994.
14. Carey TE and Bradford CR, Molecular Biology of Head and Neck Tumors. In: Comprehensive Management of Head and Neck Tumors. (2nd Ed). SE Thawley, WR Panje, JG Batsakis, and RD Lindberg (eds.). W.B. Saunders, Philadelphia, PA, pp. 321-342, 1999.
15. Lansford C, Grenman R, Bier H, Somers KD, Kim S-Y, Whiteside TL, Clayman G and Carey TE. Head and Neck Cancers. In: Human Cell Culture Vol 2, Cancer Cell Lines Part 2. J Masters (ed), Kluwer Academic Press, Dordrecht (Holland), pp. 185-255, 2000.
16. Carey TE and Bradford CR. Molecular Biology of Laryngeal Cancer. In: Diseases of the Larynx. A Ferlito (ed), Arnold Publishing, London (published in the US by Oxford University Press, New York) pp. 533-539, 2000.
17. Carey, TE, Nair, TS, Gray, JP, Zeitoun, H, Lansford, CD, Fisher, SG, Dolan, DF, Raphael, Y, Miller, JM, Ramakrishnan, A, Lee, DJ, Denny, ED, Arts, HA, Telian, SA, El-Kashlan, H, Disher, MJ, Sataloff, RT, Yeom, K. The Search for the Inner Ear Antigen of Autoimmune Sensorineural Hearing Loss, In: Immuno- and Molecular Biology in ORL – State of the Art, JE Veldman, D Passali, DJ Lim (eds.), Kugler Publications, The Hague, The Netherlands, pp. 60-67, 2000.
18. Carey TE and Wennerberg J. Cellular and Molecular Biology of the Cancer Cell. In: Head and Neck Pathology: With Clinical Correlations. Y-S Fu, B. Wenig, E. Abemayor, and B.Wenig (eds), Churchill Livingstone, New York, NY,
pp. 3-37, 2001.
19. Mertens, Fredrik and Carey, Thomas E. Solid Tumor Cytogenetics. In: Clinical Laboratory Medicine. McClatchey KD (ed.). Williams & Wilkins, Baltimore, MD, 2nd Edition, In progress.

GO TO: Research Interests

RETURN TO TOP